Page 63 - SAMRC Strategic Plan
P. 63

segments of the global population, particularly in   and new pandemics due to the spread, reemergence
            less developed countries, either lack access to these   and/or emergence of pathogens, with developing
            essential health tools or have limited access.     countries  being  more  vulnerable  geographically,
                                                               macroeconomically  and  in  terms  of  access  to
            That the COVID-19 pandemic underscored the         necessary products and technologies.
            strategic importance of health technologies
            availability,  including  vaccines,  diagnostics,  That global efforts for the prevention of, preparedness
            therapeutics and other health products, during     for, and response to existing epidemics and Public
            a pandemic emergency and revealed the limited      Health Emergencies of International Concern will
            production capacity in several regions. The        only be viable if we promote:
            COVID-19 pandemic demonstrated that market-        •  Equitable and geographically diverse distribution
            driven mechanisms often override public health        of production capacity;
            needs, as wealthier countries secured vast quantities   •  Robust and sustainable investments in research
            of vaccines early on, while the global Covax-WHO      and development, innovation, and production and
            mechanism  lacked  sufficient  funding  to  ensure    supply processes in Global South countries, and
            equitable access, resulting in significant cases and   •  Fair, transparent, and equitable mechanisms for
            deaths and disruption of health systems in Global     pricing, licensing, and technology transfer that
            South countries.                                      prioritise  south/south,  co-developed  approaches
                                                                  to cooperation between north and South and
            That, considering the COVID-19 pandemic, we have      equitable access.
            witnessed the high degree of dependency of Global
            South countries on imports of active ingredients or
            pharmaceutical products, as well as various medical   Therefore, We urge:
            supplies and equipment, underscoring the need      First:  Allies and strategic partners to learn from
            to learn lessons to avoid repeating these issues in   the COVID-19 experience, to work together to
            Public Health Emergencies of International Concern.   overcome disparities in access between and within
                                                               Global North and Global South countries, and to
            That a key lesson from the COVID-19 pandemic is    join forces, collaborate, engage in dialogue, and
            that we will not achieve equity in access to vaccines,   prioritise common  issues and  challenges,  with
            treatments, diagnostics, and other strategic health   the aim of enhancing international cooperation
            tools and supplies, nor meet the needs of our      in science and technology, accelerating local and
            populations,  if we rely solely on the research and   regional research and development, technology
            development, and production capabilities of Global   transfer, and innovation processes for the production
            North countries.                                   of vaccines, treatments, diagnostics, and other
                                                               health technologies to counter existing epidemic
            That continued investment in building and          and pandemic threats in less developed countries.
            strengthening the science, technology, and
            innovation systems, and the regional and local     Second:   Funders,  regional  and   multilateral
            end-to-end production capacity of Global South     organizations, cooperation agencies, public, private
            countries, is crucial for greater autonomy and stability   and not for-profit research organisations, civil society
            in developing health technologies, promoting       and other international community stakeholders to
            the generation and absorption of knowledge and     prioritise the development of cooperation projects
            technologies, and ensuring equitable access.       and equitable access policies and funding conditions
                                                               that focus on end-to-end research and development,
            That the advancing climate crisis and natural      transparency, knowledge-sharing,  and technology
            disasters alters patterns of infectious diseases   transfer,  and using  and  increasing  production
            including zoonotic, neglected, and vector-borne    capacity for vaccines, treatments, diagnostics, and
            diseases, and increases the likelihood of epidemics   other strategic supplies in Global South countries to



            62                       SAMRC   STRATEGIC PLAN 2025/26 – 2029/30
   58   59   60   61   62   63   64   65   66   67   68